(Date:12/2/2009)... student at the University of Southampton,s School... Oceanography Centre, Southampton (NOCS) has forma...rom the deep sea. , Hall discovered the new spec... Museum of Natural History in Washington. Explaini...rabs include some of the largest crustaceans curre...
(Date:12/1/2009)...VALE, Calif., Dec. 1 GestureTek In... 3.0 - a turnkey, portable, plug and play interact...ibits, entertainment and touring promotions. Gestu...nts in camera-enabled gesture recognition technolo...tainment systems. ,, Guaranteed for quality, th...
(Date:12/1/2009)...inner of the 2009 Inserm Grand Prix., Every year... paying tribute to outstanding,work performed in ...ents, Inserm intends to,demonstrate the diversity...ogical, medical and,health research, and the crea...out and,drive this research each day. The Inserm ...
Breaking Biology News(10 mins):King crab family bigger than ever 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3Abbott Expands XIENCE V 28R 29 USA Trial to Enroll Patients into Landmark Dual Anti Platelet Therapy 28DAPT 29 Trial 13549 1Abbott Expands XIENCE V 28R 29 USA Trial to Enroll Patients into Landmark Dual Anti Platelet Therapy 28DAPT 29 Trial 13549 2Abbott Expands XIENCE V 28R 29 USA Trial to Enroll Patients into Landmark Dual Anti Platelet Therapy 28DAPT 29 Trial 13549 3Abbott Expands XIENCE V 28R 29 USA Trial to Enroll Patients into Landmark Dual Anti Platelet Therapy 28DAPT 29 Trial 13549 4PharmAthene Reports Second Quarter 2009 Financial and Operational Results 13548 1PharmAthene Reports Second Quarter 2009 Financial and Operational Results 13548 2PharmAthene Reports Second Quarter 2009 Financial and Operational Results 13548 3PharmAthene Reports Second Quarter 2009 Financial and Operational Results 13548 4PharmAthene Reports Second Quarter 2009 Financial and Operational Results 13548 5PharmAthene Reports Second Quarter 2009 Financial and Operational Results 13548 6PharmAthene Reports Second Quarter 2009 Financial and Operational Results 13548 7PharmAthene Reports Second Quarter 2009 Financial and Operational Results 13548 8Boozing Blunts Ability to Read Faces 54415 1Boozing Blunts Ability to Read Faces 54415 2(Date:12/1/2009)..., NEW YORK, Dec. 1 Reportlinker.... available in its catalogue: ,, Industrial Enz...eportlinker.com/p0164431/Industrial-Enzymes---A-Gl...market is an oligopoly with few strong players and... activities. Keen competition and commoditization ...
(Date:12/1/2009)..., Former Majority Leader Richard Gephardt Brings ...e, Biotech Communities for "Best and Brightest Fo...J., Dec. 1 Several of N...ticals, research, medicine and technology gathered...e importance of medical innovation in New Jersey, ...
(Date:12/1/2009)...N FRANCISCO, Dec. 1 The Burrill Bi...f the value it lost in October. The Select,s gain ... month for the general markets with the Dow up 6.5...he gains held firm in the final two trading days o...h Thanksgiving holiday shopping and Dubai,s report...
(Date:12/1/2009)...ANBURY, N.J., Dec. 1 Pal...nnounced that the U.S. Patent and Trademark Office...lic Natriuretic Peptide Constructs." The claims i...unds that bind to natriuretic peptide receptor A (...lure drug candidate. ,, "Our natriuretic compou...
Breaking Biology Technology:Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 2Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 3...g radio frequency identification (RFID) software f...en is the world,s largest manufacturer of cordless...Best Buy prompted Uniden to engage the supply chai...e telephone maker is using CatalystCommand iRFID t...y chain environment. , ,Uniden America Corp. is t...
...ll begins its 2005 season, researchers at the Uni... to demonstrate their school spirit. The only fans... high-powered microscopes. , ,Last month a team of...rs created "NanoBucky", an image of the universit...nometers long. With each nanofiber a thousandth th...
...tunity to define public discourse over nanotechnol...le information about the emerging technology, a Un... says. , ,"The message to scientists is: The publi...ur work to the public, and make it available where...ed one of the first national surveys on public kno...
Other Biology Technology:Nanotechnology minimizes UW's beloved mascot 2UW study examines public attitudes on nanotechnology 2...r 2-D separations. The cell has a six-gel capacity...II xi multi-cell can be customized for several par...nd cooling system. The PROTEAN II xi multi-cell ca...l for a wider format that accommodates 17 and 18 c...
PROTEAN II xi Cell, 16 cm, without spacers and combs from Bio-Rad
CleanCut Agarose, 2%, 12 ml from Bio-Rad
Safire 2 from Tecan
Biology Products: